Skip to content

Amotivational Syndrome and Fatigue in Neurosurgery

Amotivational Syndrome and Fatigue in Neurosurgery: The Impact of Neuroinflammation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04907513
Acronym
DENI-CARE
Enrollment
25
Registered
2021-05-28
Start date
2021-12-04
Completion date
2024-12-01
Last updated
2023-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Injury, Fatigue, Motivation

Keywords

cerebrospinal fluid

Brief summary

Depression is a major public concern associated with profound distress, intense suffering, and impairment in social, professional and familial functioning. Among the numerous symptoms defining depression, fatigue and motivation are not only frequent but also highly associated with poor quality of life and resistance to conventional antidepressant. Recent data, mainly obtained in animals, suggest that these symptoms may be linked to inflammatory processes within the central nervous system. Yet access to the brain is too invasive for exploring this link in patients with psychiatric conditions. However, certain conditions in neurosurgery, such as aneurysm rupture, require external evacuation, over several days or weeks, of the fluid bathing the brain through a catheter directly inserted into it. Critically, these patients also exhibit extreme exhaustion and fluctuating motivation, allowing to investigate the involvement of neuroinflammation in lack of motivation and fatigue by carrying out repeated motivation assessments with short behavioral tests (around ten minutes), while performing an analysis of inflammation markers in the fluid evacuated from the brain. The identification of inflammatory mechanisms underlying lack of motivation and fatigue could lead to the development of treatments for both resistant depression and motivation deficits that largely hamper rehabilitation in neurosurgery.

Interventions

OTHERAssessment of the Motivational State

A motivational interviewing algorithm developed in Rothschild Hospital for this study will be used. The results range between 0% (worst motivational state) to 100% (best motivational state).

Sponsors

Fondation Ophtalmologique Adolphe de Rothschild
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* Age \>= 18 years old * Patients required an external cerebrospinal fluid drainage

Exclusion criteria

* Pregnant or breast feeding patient * Patient under legal protection * Patient opposition to participate in this study

Design outcomes

Primary

MeasureTime frameDescription
Nerotransmitter levels in cerebrospinal fuid in relation to patient motivational condition36 monthsStudy the correlation between serotonin, dopamin and glutamate concentrations in the cerebrospinal fluid with the motivational state of the patients

Countries

France

Contacts

Primary ContactPierre Bourdillon, MD, PhD
pbourdillon@for.paris(0)148036862
Backup ContactAmélie Yavchitz, MD,PhD
ayavchitz@for.paris(0)148036454

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026